Lung Cancer News and Research

RSS
Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).
Vaccinating against certain cancer proteins can boost overall immune response and shrink tumors

Vaccinating against certain cancer proteins can boost overall immune response and shrink tumors

Novel nanofluidic device for exosome nanoporation

Novel nanofluidic device for exosome nanoporation

Stem-like T cells found in certain lymph nodes could be natural cancer fighters

Stem-like T cells found in certain lymph nodes could be natural cancer fighters

Scientists develop lung organoids to imitate actual SARS-CoV-2 infection

Scientists develop lung organoids to imitate actual SARS-CoV-2 infection

New molecule can effectively deplete cancer-protecting cells inside tumors

New molecule can effectively deplete cancer-protecting cells inside tumors

New technique to hunt down mutations that cause cancer drug resistance

New technique to hunt down mutations that cause cancer drug resistance

Research provides a detailed 'proteogenomic' view of lung squamous cell carcinoma

Research provides a detailed 'proteogenomic' view of lung squamous cell carcinoma

New multimodal diagnostic can detect cancer cells and pinpoint tumor location

New multimodal diagnostic can detect cancer cells and pinpoint tumor location

Natural killer cells target breast cancer using the body’s immune system

Natural killer cells target breast cancer using the body’s immune system

Breast cancer survivors have higher risk of new cancer diagnosis compared to healthy individuals

Breast cancer survivors have higher risk of new cancer diagnosis compared to healthy individuals

Modified immune cells can ruthlessly kill cancerous tumors

Modified immune cells can ruthlessly kill cancerous tumors

Researchers identify and test drug combination that exploits a weakness in small cell lung cancer

Researchers identify and test drug combination that exploits a weakness in small cell lung cancer

Scientists discover mutations that make cancer resistant to KRAS-targeted therapies

Scientists discover mutations that make cancer resistant to KRAS-targeted therapies

High expression of cell death genes linked to increased risk of dying early from lung cancer

High expression of cell death genes linked to increased risk of dying early from lung cancer

Rare genetic variants contribute to increased risk for lung cancer

Rare genetic variants contribute to increased risk for lung cancer

Study reveals substantial difference in selection and timing of genetic tests for non-small-cell lung cancer

Study reveals substantial difference in selection and timing of genetic tests for non-small-cell lung cancer

Study reveals molecular profiles of Parkinson's disease

Study reveals molecular profiles of Parkinson's disease

Adhesion strength and contractility enable metastatic cancer cells to display adurotactic behavior

Adhesion strength and contractility enable metastatic cancer cells to display adurotactic behavior

Immune cells in cerebrospinal fluid could be biomarkers to predict immunotherapy response

Immune cells in cerebrospinal fluid could be biomarkers to predict immunotherapy response

New algorithm identifies 'escaping' cells in single-cell CRISPR screens

New algorithm identifies 'escaping' cells in single-cell CRISPR screens

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.